| Detected | Trial | Change |
|---|---|---|
| 2026-07-29 | NCT07726368 Study of ECC4703 With Sulfasalazine and Pitavastatin |
Primary endpoint(s) modified |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-24 | NCT07726368 Study of ECC4703 With Sulfasalazine and Pitavastatin | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07288138 | A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide… | Metabolic Dysfunction-associated Steatohepatitis | Recruiting |
| NCT07505303 | MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial | Adult Obesity | Active, Not Recruiting |
| Phase 1 | |||
| NCT07334080 | ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants | Metabolic Dysfunction-Associated Steatohepatitis | Recruiting |
| NCT07726368 | Study of ECC4703 With Sulfasalazine and Pitavastatin | Non-alcoholic Fatty Liver Disease (NAFLD) | Not Yet Recruiting |